MedTrace Logo

Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease

NCT06288204 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2026-05-15

No results posted yet for this study

Summary

This work aims to evaluate the effects of the association of green propolis extract with royal jelly on inflammation and oxidative stress in participants with chronic kidney diseases (CKD) and Systemic arterial hypertension (SAH), in a longitudinal, randomized, double-blind, placebo-controlled clinical trial that will be carried out for 2 months.

Conditions

Interventions

DIETARY_SUPPLEMENT

Propolis associated with Royal Jelly

The participants will consume 4 capsules a day, providing daily royal jelly in an amount of 100 mg/day plus 500 mg/day of propolis together, for 2 months.

DIETARY_SUPPLEMENT

Royal Jelly

The participants will consume 1 capsules a day, providing daily royal jelly in an amount of 100 mg/day, for 2 months.

DIETARY_SUPPLEMENT

Placebo

The participant will consume 4 capsules a day of placebo, for 2 months.

Sponsors & Collaborators

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV

  • Rio de Janeiro State Research Supporting Foundation (FAPERJ)

    collaborator OTHER_GOV

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

    collaborator OTHER_GOV

  • Universidade Federal Fluminense

    lead OTHER

Principal Investigators

  • Denise Mafra, PhD · Universidade Federal Fluminense

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2026-12-31
Completion
2027-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06288204 on ClinicalTrials.gov